- Low
- 52,000
- Average
- 113,847
- Median
- 118,000
- High
- 180,000
Nabsys Salary
58
47
27
Nabsys average salary is $113,847, median salary is $118,000 with a salary range from $52,000 to $180,000.
Nabsys salaries are collected from government agencies and companies. Each salary is associated with a real job position. Nabsys salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Nabsys salaries are collected from government agencies and companies. Each salary is associated with a real job position. Nabsys salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Related Nabsys Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Nabsys salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Guyp Salary Nabsys Jobs
| See more Nabsys Jobs» | |
| Search All Jobs | |
Patents information
75
All Patents
25
Grant Patents
50
Patents Pending
25
Patents Families
More Recent
-
US11274341B2Assay methods using DNA binding proteins
-
US10583441B2Self-sealing pipette septum
-
EP2956550B1ENHANCED PROBE BINDING
- View More »
Nabsys... Information
- NABsys Inc
- Industry: Biotech/Healthcare
- City: Providence, RI
- NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care. Our approach builds on existing solid-state technologies to create a whole-genome sequencing technology that employs electronic detection, does not depend on a polymerase, and directly obtains DNA sequence information over hundreds of thousands of bases.
